1/363
Looks like no tags are added yet.
Q: What is a thrombus?
A: A blood clot that forms and remains inside a blood vessel.
Q: What is an embolus?
A: A clot or other material that travels through circulation and lodges in another vessel.
Q: What is venous thromboembolism (VTE)?
A: A condition involving DVT and/or PE.
Q: What is DVT?
A: A thrombus that forms in a deep vein, most commonly in the lower extremities.
Q: What is PE?
A: An embolus, usually from a DVT, that obstructs a pulmonary artery.
Q: What are the three parts of Virchow's triad?
A: Venous stasis, endothelial injury, and hypercoagulability.
Q: What is venous stasis?
A: Slowed blood flow, often caused by immobility, bed rest, or prolonged travel.
Q: What causes endothelial injury?
A: Surgery, trauma, and catheters.
Q: What causes hypercoagulability?
A: Cancer, pregnancy, and inherited thrombophilia.
Q: What forms a blood clot?
A: Platelets, fibrin, and red blood cells.
Q: How can a DVT cause a PE?
A: A clot breaks loose, travels through circulation, and obstructs a pulmonary artery. Q: What happens during DVT pathophysiology?
A: Virchow's triad → thrombus forms → venous obstruction → increased venous pressure → impaired return → swelling and pain.
Q: What are the major DVT risk factors?
A: Immobility, hospitalization, prolonged travel, surgery, trauma, cancer, pregnancy, estrogen, obesity, and previous DVT.
Q: What are the clinical manifestations of DVT?
A: Unilateral leg swelling, calf pain/tenderness, warmth, erythema, or discoloration.
Q: Can a patient have DVT without symptoms?
A: Yes, DVT may be asymptomatic.
Q: What is post-thrombotic syndrome?
A: Venous valve damage causing chronic edema, pain, skin changes, or ulcers.
Q: What is phlegmasia cerulea dolens?
A: Severe venous obstruction that can cause limb ischemia.
Q: What is the Wells score used for?
A: Estimating the clinical probability of DVT or PE.
Q: What does an elevated D-dimer indicate?
A: Increased clot breakdown; it is nonspecific and does not confirm DVT or PE.
Q: When is a negative D-dimer useful?
A: It can help exclude DVT in appropriately selected low-risk patients.
Q: What is the first-line imaging test for DVT?
A: Venous duplex ultrasound.
Q: What does a positive venous duplex ultrasound show?
A: The vein does not compress normally, suggesting a clot.
Q: When might CT or MR venography be used?
A: When ultrasound is inconclusive or a pelvic clot is suspected.
Q: What is the first-line treatment for most DVTs?
A: Anticoagulation.
Q: What do anticoagulants do for DVT?
A: Prevent clot formation and extension; they do not directly dissolve the existing clot.
Q: Which anticoagulants may be used for DVT?
A: DOACs such as apixaban or rivaroxaban, UFH, LMWH, or warfarin.
Q: What is the typical minimum duration of DVT anticoagulation?
A: Generally at least 3 months, followed by reassessment.
Q: What should the nurse monitor in a patient receiving anticoagulants?
A: Bleeding, relevant laboratory results, platelets when indicated, and signs of PE.
Q: What should the nurse assess when DVT is suspected?
A: Compare extremities and assess swelling, pain, warmth, and discoloration.
Q: Should a suspected DVT leg be massaged?
A: No. Do not massage the affected leg.
Q: When can a patient with DVT begin ambulating?
A: Once appropriately anticoagulated and clinically stable.
Q: How can DVT be prevented?
A: Early ambulation, leg exercises, repositioning, movement during travel, SCDs when appropriate, and prescribed pharmacologic prophylaxis.
Q: What do SCDs do?
A: Promote venous return and reduce venous stasis.
Q: What medications may be used for VTE prophylaxis?
A: Low-dose unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH).